Ion pairs of risedronate for transdermal delivery and enhanced permeation rate on hairless mouse skin

International Journal of Pharmaceutics

Volumn 419, Issue 1-2, 2011, Pages 114-120

  Nam, So Hee ^a   Xu, Ying Ji ^a   Nam, Hyemi ^a   Jin, Geun Woo ^a   Jeong, Yunseong ^a   An, Songhie ^a   Park, Jong Sang ^a  

^a Seoul National University   (South Korea)

Author keywords

Bisphosphonate; Ion pairs; Risedronate; Transdermal delivery

Indexed keywords

ARGININE; DIETHYLENETRIAMINE; LYSINE; RISEDRONIC ACID; XYLENE;

ANIMAL EXPERIMENT; ARTICLE; CHEMICAL STRUCTURE; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG SOLUBILITY; EDEMA; ERYTHEMA; HAIRLESS MOUSE; IN VITRO STUDY; ION TRANSPORT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN; SKIN IRRITATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; ARGININE; BONE DENSITY CONSERVATION AGENTS; ETIDRONIC ACID; EXCIPIENTS; IONS; LYSINE; MICE; MICE, HAIRLESS; PERMEABILITY; POLYAMINES; SKIN ABSORPTION; SOLUBILITY; SOLVENTS; WATER; XYLENES;

EID: 80053565976     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.07.027     Document Type: Article

References (41)

1. B. Abrahamsen Adverse effects of bisphosphonates Calcif. Tissue Int. 86 2010 421 435
2. L.A. Assael Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies J. Oral Maxillofac. Surg. 67 2009 35 43
3. S. Banerjee, S.H. Yalkowsky, and C. Valvani Water solubility and octanol/water partition coefficients of organics. Limitations of the solubility-partition coefficient correlation Environ. Sci. Technol. 14 1980 1227 1229 (Pubitemid 10030051)
4. B. Barry Mode of action of penetration enhancers in human skin J. Control. Release 6 1987 85 97 (Pubitemid 18017724)
5. B. Barry Novel mechanisms and devices to enable successful transdermal drug delivery Eur. J. Pharm. Sci. 14 2001 101 114 (Pubitemid 32737532)
6. B. Barry Drug delivery routes in skin: a novel approach Adv. Drug Deliv. Rev. 54 2002 S31 S40
7. F. Benavides, T.M. Oberyszyn, A.M. VanBuskirk, V.E. Reeve, and D.F. Kusewitt The hairless mouse in skin research J. Dermatol. Sci. 53 2009 10 18
8. T. Brinkmeier, K. Kügler, J.-P. Lepoittevin, and P.J. Frosch Adverse cutaneous drug reaction to alendronate Contact Dermat. 57 2007 123 125 (Pubitemid 47052275)
9. R.L. Bronaugh, R.F. Stewart, and E.R. Congdon Methods for in vitro percutaneous absorption studies. II. Animal models for human skin Toxicol. Appl. Pharmacol. 62 1982 481 488 (Pubitemid 12136695)
10. J.K. Brooks, A.J. Gilson, A.J. Sindler, S.G. Ashman, K.G. Schwartz, and N.G. Nikitakis Osteonecrosis of the jaws associated with use of risedronate: report of 2 new cases Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 103 2007 780 786
11. M.B. Brown, G.P. Martin, S.A. Jones, and F.K. Akomeah Dermal and transdermal drug delivery systems: current and future prospects Drug Deliv. 13 2006 175 187
12. A. Fini, G. Fazio, M. Gonzalez-Rodriguez, C. Cavallari, N. Passerini, and L. Rodriguez Formation of ion-pairs in aqueous solutions of diclofenac salts Int. J. Pharm. 187 1999 163 173 (Pubitemid 29443896)
13. B. Forslind A domain mosaic model of the skin barrier Acta Derm. Venereol. 74 1994 1
14. P. Greenspan, and R.L. Gutman Detection by nile red of agarose gel electrophoresed native and modified low density lipoprotein Electrophoresis 14 1993 65 68 (Pubitemid 23074201)
15. V.D. Ivaturi, and S.K. Kim Enhanced permeation of methotrexate in vitro by ion pair formation with l-arginine J. Pharm. Sci. 98 2009 3633 3639
16. J. Kao, J. Hall, and G. Helman In vitro percutaneous absorption in mouse skin: influence of skin appendages Toxicol. Appl. Pharmacol. 94 1988 93 103
17. K. Kusamori, H. Katsumi, M. Abe, A. Ueda, R. Sakai, R. Hayashi, Y. Hirai, Y.-S. Quan, F. Kamiyama, T. Sakane, and A. Yamamoto Development of a novel transdermal patch of alendronate, a nitrogen-containing bisphosphonate, for the treatment of osteoporosis J. Bone Miner. Res. 25 2010 2582 2591
18. A.C. Lauer, L.M. Lieb, C. Ramachandran, G.L. Flynn, and N.D. Weiner Transfollicular drug delivery Pharm. Res. 12 1995 179 186
19. X. Ma, L. Fang, J. Guo, N. Zhao, and Z. He Effect of counter ions and penetration enhancers on the skin permeation of flurbiprofen J. Pharm. Sci. 99 2010 1826 1837
20. S.A. Megwa, S.E. Cross, H.A.E. Benson, and M.S. Roberts Ion pair formation as a strategy to enhance topical delivery of salicylic acid J. Pharm. Pharmacol. 52 2000 919 928
21. A. Michaels, S. Chandrasekaran, and J. Shaw Drug permeation through human skin: theory and in vitro experimental measurement AIChE J. 21 1975 985 996
22. D.Y. Mitchell, M.A. Heise, K.A. Pallone, M.E. Clay, J.D. Nesbitt, D.A. Russell, and C.W. Melson The effect of dosing regimen on the pharmacokinetics of risedronate Br. J. Clin. Pharmacol. 48 1999 536 542 (Pubitemid 29454234)
23. A. Naik, Y.N. Kalia, and R.H. Guy Transdermal drug delivery: overcoming the skin's barrier function Pharmaceut. Sci. Technol. Today 3 2000 318 326
24. R. Neubert Ion pair transport across membranes Pharm. Res. 6 1989 743 747 (Pubitemid 19247842)
25. J. Novotny, P. Kova ikova, M. Novotny, B. Jan ova, A. Hrabalek, and K. Vavrova Dimethylamino acid esters as biodegradable and reversible transdermal permeation enhancers: effects of linking chain length, chirality and polyfluorination Pharm. Res. 26 2009 811 821
26. A. Pardo, Y. Shiri, and S. Cohen Percutaneous absorption of physostigmine: optimization of delivery from a binary solvent by thermodynamic control J. Pharm. Sci. 79 1990 573 578 (Pubitemid 20222719)
27. R.O. Potts, and R.H. Guy Predicting skin permeability Pharm. Res. 9 1992 663 669
28. M.R. Prausnitz, and R. Langer Transdermal drug delivery Nat. Biotechnol. 26 2008 1261 1268
29. J. Prue Ion pairs and complexes: free energies, enthalpies, and entropies J. Chem. Educ. 46 1969 12
30. C. Ramachandran, and D. Fleisher Transdermal delivery of drugs for the treatment of bone diseases Adv. Drug Deliv. Rev. 42 2000 197 223 (Pubitemid 30645778)
31. S. Ruggiero, and S. Drew Osteonecrosis of the jaws and bisphosphonate therapy J. Dent. Res. 86 2007 1013
32. S.L. Ruggiero, B. Mehrotra, T.J. Rosenberg, and S.L. Engroff Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases J. Oral Maxillofac. Surg. 62 2004 527 534 (Pubitemid 38542516)
33. A. Ruland, and J. Kreuter Influence of various penetration enhancers on the in vitro permeation of amino acids across hairless mouse skin Int. J. Pharm. 85 1992 7 17
34. I.Z. Schroeder, P. Franke, U.F. Schaefer, and C.M. Lehr Delivery of ethinylestradiol from film forming polymeric solutions across human epidermis in vitro and in vivo in pigs J. Control. Release 118 2007 196 203 (Pubitemid 46329735)
35. D.H. Solomon, L. Rekedal, and S.M. Cadarette Osteoporosis treatments and adverse events Curr. Opin. Rheumatol. 21 2009 363
36. K. Takacs-Novak, and G. Szasz Ion-pair partition of quaternary ammonium drugs: the influence of counter ions of different lipophilicity, size, and flexibility Pharm. Res. 16 1999 1633 1638 (Pubitemid 29510564)
37. Z. Tan, J. Zhang, J. Wu, L. Fang, and Z. He The Enhancing Effect of Ion-pairing on the skin permeation of glipizide AAPS PharmSciTech 10 2009 967 976
38. K. Vávrová, K. Lorencová, J. Klimentová, J. Novotný, A. Holý, and N.A. Hrabálek Transdermal and dermal delivery of adefovir: effects of pH and permeation enhancers Eur. J. Pharm. Biopharm. 69 2008 597 604
39. C. Valenta, U. Siman, M. Kratzel, and J. Hadgraft The dermal delivery of lignocaine: influence of ion pairing Int. J. Pharm. 197 2000 77 85 (Pubitemid 30125779)
40. M. Wang, L. Fang, C. Ren, and T. Li Effect of ion pairing and enhancers on scutellarin skin permeability J. Pharm. Pharmacol. 60 2008 429 435 (Pubitemid 351500553)
41. P.K. Wotton, B. Møllgaard, J. Hadgraft, and A. Hoelgaard Vehicle effect on topical drug delivery. III. Effect of azone on the cutaneous permeation of metronidazole and propylene glycol Int. J. Pharm. 24 1985 19 26 (Pubitemid 15110894)